Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO2754 | Iryanthera lancifolia | Species | Myristicaceae | Eukaryota |
PMID[18242997] |
|||
NPO2754 | Iryanthera lancifolia | Species | Myristicaceae | Eukaryota |
PMID[10579855] |
|||
NPO583 | Goniothalamus gardneri | Species | Annonaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT83 | Cell Line | MCF7 | Homo sapiens | Ratio | = | 6.6 | 18242997 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 0.01 | % | 18242997 |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 80.7 | % | 18242997 |
NPT886 | Cell Line | NIH3T3 | Mus musculus | GI50 | = | 42.5 | ug/ml | 18163590 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 44.7 | ug/ml | 18163590 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 41.7 | ug/ml | 18163590 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 22.9 | ug/ml | 18163590 |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | = | 40.3 | ug/ml | 18163590 |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | = | 35.5 | ug/ml | 18163590 |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | = | 46.3 | ug/ml | 18163590 |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | = | 7.4 | ug/ml | 18163590 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | GI50 | = | 40.4 | ug/ml | 18163590 |
NPT886 | Cell Line | NIH3T3 | Mus musculus | GI50 | > | 206000 | nM | 18798609 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 128000 | nM | 18798609 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | > | 206000 | nM | 18798609 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 65500 | nM | 18798609 |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | = | 109200 | nM | 18798609 |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | > | 206000 | nM | 18798609 |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | = | 59900 | nM | 18798609 |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | = | 22800 | nM | 18798609 |
NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | > | 25000 | nM | 18798609 |
NPT2 | Others | Unspecified | Activity | = | 6.9 | ug/ml | 10579855 | |
NPT886 | Cell Line | NIH3T3 | Mus musculus | GI50 | = | 140600 | nM | 19199646 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 147900 | nM | 19199646 |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 137900 | nM | 19199646 |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 75700 | nM | 19199646 |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | = | 133300 | nM | 19199646 |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | = | 117400 | nM | 19199646 |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | = | 153100 | nM | 19199646 |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | = | 24500 | nM | 19199646 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | GI50 | = | 133600 | nM | 19199646 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC20560 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC144051 |
1.0 | High Similarity | NPC28753 |
1.0 | High Similarity | NPC18877 |
1.0 | High Similarity | NPC82225 |
1.0 | High Similarity | NPC159623 |
1.0 | High Similarity | NPC204960 |
1.0 | High Similarity | NPC294593 |
0.9922 | High Similarity | NPC286336 |
0.9845 | High Similarity | NPC13575 |
0.9844 | High Similarity | NPC472365 |
0.9844 | High Similarity | NPC139813 |
0.9844 | High Similarity | NPC175098 |
0.9844 | High Similarity | NPC263670 |
0.9844 | High Similarity | NPC188646 |
0.9844 | High Similarity | NPC192304 |
0.9844 | High Similarity | NPC242294 |
0.9844 | High Similarity | NPC337373 |
0.9844 | High Similarity | NPC312318 |
0.9844 | High Similarity | NPC56031 |
0.9843 | High Similarity | NPC186097 |
0.9843 | High Similarity | NPC475009 |
0.9843 | High Similarity | NPC475008 |
0.9769 | High Similarity | NPC168105 |
0.9769 | High Similarity | NPC66349 |
0.9769 | High Similarity | NPC98115 |
0.9769 | High Similarity | NPC150399 |
0.9769 | High Similarity | NPC249606 |
0.9769 | High Similarity | NPC477242 |
0.9769 | High Similarity | NPC12165 |
0.9769 | High Similarity | NPC186838 |
0.9769 | High Similarity | NPC41461 |
0.9769 | High Similarity | NPC25287 |
0.9769 | High Similarity | NPC477243 |
0.9769 | High Similarity | NPC1486 |
0.9769 | High Similarity | NPC274109 |
0.9769 | High Similarity | NPC477244 |
0.9767 | High Similarity | NPC103842 |
0.9766 | High Similarity | NPC87231 |
0.9766 | High Similarity | NPC205468 |
0.9766 | High Similarity | NPC129132 |
0.9766 | High Similarity | NPC257756 |
0.9766 | High Similarity | NPC212631 |
0.9695 | High Similarity | NPC472419 |
0.9695 | High Similarity | NPC153979 |
0.9695 | High Similarity | NPC317119 |
0.9692 | High Similarity | NPC131039 |
0.9692 | High Similarity | NPC156092 |
0.9688 | High Similarity | NPC262359 |
0.9688 | High Similarity | NPC308037 |
0.9688 | High Similarity | NPC309717 |
0.9688 | High Similarity | NPC128348 |
0.9688 | High Similarity | NPC313618 |
0.9688 | High Similarity | NPC66384 |
0.9688 | High Similarity | NPC112192 |
0.9688 | High Similarity | NPC164236 |
0.9688 | High Similarity | NPC64359 |
0.9688 | High Similarity | NPC189106 |
0.9621 | High Similarity | NPC472368 |
0.9621 | High Similarity | NPC21350 |
0.9621 | High Similarity | NPC124269 |
0.9621 | High Similarity | NPC251681 |
0.9621 | High Similarity | NPC243528 |
0.9618 | High Similarity | NPC473391 |
0.9618 | High Similarity | NPC476333 |
0.9618 | High Similarity | NPC213603 |
0.9618 | High Similarity | NPC472367 |
0.9618 | High Similarity | NPC472364 |
0.9549 | High Similarity | NPC477956 |
0.9549 | High Similarity | NPC470211 |
0.9549 | High Similarity | NPC472366 |
0.9545 | High Similarity | NPC303644 |
0.9545 | High Similarity | NPC188879 |
0.9545 | High Similarity | NPC116632 |
0.9545 | High Similarity | NPC162680 |
0.9545 | High Similarity | NPC7013 |
0.9545 | High Similarity | NPC209560 |
0.9545 | High Similarity | NPC181124 |
0.9545 | High Similarity | NPC294409 |
0.9538 | High Similarity | NPC27643 |
0.9531 | High Similarity | NPC247779 |
0.9478 | High Similarity | NPC172250 |
0.9478 | High Similarity | NPC215311 |
0.9478 | High Similarity | NPC213659 |
0.9478 | High Similarity | NPC6407 |
0.9478 | High Similarity | NPC48624 |
0.9478 | High Similarity | NPC129853 |
0.9478 | High Similarity | NPC159275 |
0.9478 | High Similarity | NPC110228 |
0.9478 | High Similarity | NPC76445 |
0.9478 | High Similarity | NPC265178 |
0.9478 | High Similarity | NPC188243 |
0.9478 | High Similarity | NPC284550 |
0.9478 | High Similarity | NPC241100 |
0.9478 | High Similarity | NPC11056 |
0.9478 | High Similarity | NPC259166 |
0.9478 | High Similarity | NPC219917 |
0.9478 | High Similarity | NPC326109 |
0.9478 | High Similarity | NPC204985 |
0.9478 | High Similarity | NPC144118 |
0.9478 | High Similarity | NPC80962 |
0.9474 | High Similarity | NPC471620 |
0.9474 | High Similarity | NPC90665 |
0.9474 | High Similarity | NPC279668 |
0.9474 | High Similarity | NPC278323 |
0.9474 | High Similarity | NPC309154 |
0.9474 | High Similarity | NPC55162 |
0.9474 | High Similarity | NPC12175 |
0.947 | High Similarity | NPC473887 |
0.947 | High Similarity | NPC29353 |
0.947 | High Similarity | NPC127447 |
0.947 | High Similarity | NPC194281 |
0.947 | High Similarity | NPC13408 |
0.947 | High Similarity | NPC231772 |
0.947 | High Similarity | NPC240593 |
0.947 | High Similarity | NPC234133 |
0.947 | High Similarity | NPC124784 |
0.947 | High Similarity | NPC47815 |
0.9462 | High Similarity | NPC15834 |
0.9462 | High Similarity | NPC215875 |
0.9453 | High Similarity | NPC211120 |
0.9453 | High Similarity | NPC212379 |
0.9453 | High Similarity | NPC69235 |
0.9449 | High Similarity | NPC305518 |
0.9449 | High Similarity | NPC128428 |
0.9407 | High Similarity | NPC126534 |
0.9407 | High Similarity | NPC55832 |
0.9407 | High Similarity | NPC268204 |
0.9407 | High Similarity | NPC282300 |
0.9407 | High Similarity | NPC469404 |
0.9407 | High Similarity | NPC232021 |
0.9407 | High Similarity | NPC470087 |
0.9407 | High Similarity | NPC321980 |
0.9407 | High Similarity | NPC26238 |
0.9407 | High Similarity | NPC52789 |
0.9407 | High Similarity | NPC110969 |
0.9407 | High Similarity | NPC26051 |
0.9407 | High Similarity | NPC40118 |
0.9407 | High Similarity | NPC49108 |
0.9407 | High Similarity | NPC470089 |
0.9403 | High Similarity | NPC220062 |
0.9403 | High Similarity | NPC222342 |
0.9403 | High Similarity | NPC78913 |
0.9403 | High Similarity | NPC55018 |
0.9403 | High Similarity | NPC216978 |
0.9403 | High Similarity | NPC109232 |
0.9403 | High Similarity | NPC225153 |
0.9403 | High Similarity | NPC301217 |
0.9403 | High Similarity | NPC20709 |
0.9403 | High Similarity | NPC53181 |
0.9403 | High Similarity | NPC140890 |
0.9403 | High Similarity | NPC217186 |
0.9403 | High Similarity | NPC18260 |
0.9403 | High Similarity | NPC295384 |
0.9403 | High Similarity | NPC96565 |
0.9403 | High Similarity | NPC265871 |
0.9403 | High Similarity | NPC274784 |
0.9403 | High Similarity | NPC150648 |
0.9403 | High Similarity | NPC283429 |
0.9403 | High Similarity | NPC310135 |
0.9403 | High Similarity | NPC303633 |
0.9403 | High Similarity | NPC329203 |
0.9398 | High Similarity | NPC250266 |
0.9398 | High Similarity | NPC266597 |
0.9394 | High Similarity | NPC39426 |
0.9394 | High Similarity | NPC234560 |
0.9389 | High Similarity | NPC16197 |
0.938 | High Similarity | NPC84772 |
0.9375 | High Similarity | NPC80694 |
0.9375 | High Similarity | NPC475017 |
0.9375 | High Similarity | NPC186098 |
0.9338 | High Similarity | NPC228504 |
0.9338 | High Similarity | NPC324134 |
0.9338 | High Similarity | NPC182852 |
0.9338 | High Similarity | NPC167624 |
0.9338 | High Similarity | NPC10937 |
0.9338 | High Similarity | NPC220998 |
0.9338 | High Similarity | NPC40833 |
0.9338 | High Similarity | NPC37496 |
0.9338 | High Similarity | NPC64915 |
0.9338 | High Similarity | NPC227579 |
0.9338 | High Similarity | NPC11561 |
0.9338 | High Similarity | NPC265040 |
0.9338 | High Similarity | NPC76372 |
0.9338 | High Similarity | NPC1089 |
0.9338 | High Similarity | NPC161506 |
0.9338 | High Similarity | NPC107572 |
0.9338 | High Similarity | NPC78 |
0.9338 | High Similarity | NPC166482 |
0.9338 | High Similarity | NPC324436 |
0.9338 | High Similarity | NPC66515 |
0.9338 | High Similarity | NPC328164 |
0.9338 | High Similarity | NPC297600 |
0.9338 | High Similarity | NPC177354 |
0.9338 | High Similarity | NPC306829 |
0.9338 | High Similarity | NPC125855 |
0.9338 | High Similarity | NPC32739 |
0.9338 | High Similarity | NPC296917 |
0.9338 | High Similarity | NPC223500 |
0.9338 | High Similarity | NPC148757 |
0.9338 | High Similarity | NPC226636 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC20560 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9688 | High Similarity | NPD1240 | Approved |
0.9538 | High Similarity | NPD1607 | Approved |
0.9394 | High Similarity | NPD1510 | Phase 2 |
0.9254 | High Similarity | NPD1552 | Clinical (unspecified phase) |
0.9254 | High Similarity | NPD1550 | Clinical (unspecified phase) |
0.9203 | High Similarity | NPD4378 | Clinical (unspecified phase) |
0.9185 | High Similarity | NPD1549 | Phase 2 |
0.8929 | High Similarity | NPD7410 | Clinical (unspecified phase) |
0.8897 | High Similarity | NPD2796 | Approved |
0.875 | High Similarity | NPD4380 | Phase 2 |
0.8723 | High Similarity | NPD6799 | Approved |
0.8699 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.869 | High Similarity | NPD7411 | Suspended |
0.8676 | High Similarity | NPD6651 | Approved |
0.8639 | High Similarity | NPD8443 | Clinical (unspecified phase) |
0.8633 | High Similarity | NPD970 | Clinical (unspecified phase) |
0.863 | High Similarity | NPD1934 | Approved |
0.8592 | High Similarity | NPD1511 | Approved |
0.8571 | High Similarity | NPD2801 | Approved |
0.8523 | High Similarity | NPD7075 | Discontinued |
0.8519 | High Similarity | NPD6859 | Clinical (unspecified phase) |
0.8493 | Intermediate Similarity | NPD6599 | Discontinued |
0.8489 | Intermediate Similarity | NPD2935 | Discontinued |
0.8472 | Intermediate Similarity | NPD1512 | Approved |
0.8456 | Intermediate Similarity | NPD3882 | Suspended |
0.8446 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8446 | Intermediate Similarity | NPD7819 | Suspended |
0.84 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.838 | Intermediate Similarity | NPD3750 | Approved |
0.838 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.8378 | Intermediate Similarity | NPD6801 | Discontinued |
0.8357 | Intermediate Similarity | NPD1551 | Phase 2 |
0.831 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.831 | Intermediate Similarity | NPD2800 | Approved |
0.8261 | Intermediate Similarity | NPD943 | Approved |
0.8212 | Intermediate Similarity | NPD7768 | Phase 2 |
0.8194 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.8194 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8194 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8194 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8182 | Intermediate Similarity | NPD6232 | Discontinued |
0.8182 | Intermediate Similarity | NPD2654 | Approved |
0.8169 | Intermediate Similarity | NPD2344 | Approved |
0.8158 | Intermediate Similarity | NPD3749 | Approved |
0.8151 | Intermediate Similarity | NPD2532 | Approved |
0.8151 | Intermediate Similarity | NPD2533 | Approved |
0.8151 | Intermediate Similarity | NPD2534 | Approved |
0.8148 | Intermediate Similarity | NPD1203 | Approved |
0.8146 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8141 | Intermediate Similarity | NPD7473 | Discontinued |
0.8117 | Intermediate Similarity | NPD6959 | Discontinued |
0.8088 | Intermediate Similarity | NPD2798 | Approved |
0.806 | Intermediate Similarity | NPD3972 | Approved |
0.8056 | Intermediate Similarity | NPD1243 | Approved |
0.8041 | Intermediate Similarity | NPD5403 | Approved |
0.8038 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.8028 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.8028 | Intermediate Similarity | NPD3748 | Approved |
0.8028 | Intermediate Similarity | NPD2799 | Discontinued |
0.7987 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7975 | Intermediate Similarity | NPD3818 | Discontinued |
0.7971 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7945 | Intermediate Similarity | NPD2309 | Approved |
0.7939 | Intermediate Similarity | NPD9493 | Approved |
0.7937 | Intermediate Similarity | NPD5953 | Discontinued |
0.7926 | Intermediate Similarity | NPD9717 | Approved |
0.7925 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7925 | Intermediate Similarity | NPD7054 | Approved |
0.7919 | Intermediate Similarity | NPD920 | Approved |
0.7905 | Intermediate Similarity | NPD5401 | Approved |
0.7891 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7875 | Intermediate Similarity | NPD7472 | Approved |
0.7857 | Intermediate Similarity | NPD3268 | Approved |
0.7857 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7852 | Intermediate Similarity | NPD422 | Phase 1 |
0.7852 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7847 | Intermediate Similarity | NPD6100 | Approved |
0.7847 | Intermediate Similarity | NPD6099 | Approved |
0.7842 | Intermediate Similarity | NPD4908 | Phase 1 |
0.784 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7838 | Intermediate Similarity | NPD7390 | Discontinued |
0.7826 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7821 | Intermediate Similarity | NPD5494 | Approved |
0.782 | Intermediate Similarity | NPD9545 | Approved |
0.782 | Intermediate Similarity | NPD1548 | Phase 1 |
0.78 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD7033 | Discontinued |
0.7778 | Intermediate Similarity | NPD7251 | Discontinued |
0.7754 | Intermediate Similarity | NPD2797 | Approved |
0.773 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.773 | Intermediate Similarity | NPD2313 | Discontinued |
0.773 | Intermediate Similarity | NPD7808 | Phase 3 |
0.7721 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7677 | Intermediate Similarity | NPD5402 | Approved |
0.7673 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7669 | Intermediate Similarity | NPD6559 | Discontinued |
0.7622 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.7591 | Intermediate Similarity | NPD1201 | Approved |
0.7582 | Intermediate Similarity | NPD3226 | Approved |
0.7569 | Intermediate Similarity | NPD230 | Phase 1 |
0.7554 | Intermediate Similarity | NPD3225 | Approved |
0.7554 | Intermediate Similarity | NPD1876 | Approved |
0.7536 | Intermediate Similarity | NPD1608 | Approved |
0.7535 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7534 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7534 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7532 | Intermediate Similarity | NPD919 | Approved |
0.7517 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD1470 | Approved |
0.75 | Intermediate Similarity | NPD5710 | Approved |
0.75 | Intermediate Similarity | NPD3267 | Approved |
0.75 | Intermediate Similarity | NPD1164 | Approved |
0.75 | Intermediate Similarity | NPD5711 | Approved |
0.75 | Intermediate Similarity | NPD3266 | Approved |
0.7485 | Intermediate Similarity | NPD5844 | Phase 1 |
0.7483 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7483 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7483 | Intermediate Similarity | NPD3764 | Approved |
0.7468 | Intermediate Similarity | NPD7458 | Discontinued |
0.7448 | Intermediate Similarity | NPD1933 | Approved |
0.7448 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7444 | Intermediate Similarity | NPD1241 | Discontinued |
0.7439 | Intermediate Similarity | NPD1729 | Discontinued |
0.7438 | Intermediate Similarity | NPD1247 | Approved |
0.7432 | Intermediate Similarity | NPD2346 | Discontinued |
0.7402 | Intermediate Similarity | NPD846 | Approved |
0.7402 | Intermediate Similarity | NPD940 | Approved |
0.74 | Intermediate Similarity | NPD7003 | Approved |
0.7394 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD3847 | Discontinued |
0.7389 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7384 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7384 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7372 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7372 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7365 | Intermediate Similarity | NPD5405 | Approved |
0.7365 | Intermediate Similarity | NPD5404 | Approved |
0.7365 | Intermediate Similarity | NPD5408 | Approved |
0.7365 | Intermediate Similarity | NPD5406 | Approved |
0.7361 | Intermediate Similarity | NPD6798 | Discontinued |
0.7361 | Intermediate Similarity | NPD411 | Approved |
0.7357 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7349 | Intermediate Similarity | NPD6104 | Discontinued |
0.7343 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7342 | Intermediate Similarity | NPD4288 | Approved |
0.7342 | Intermediate Similarity | NPD2296 | Approved |
0.7341 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7341 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7329 | Intermediate Similarity | NPD447 | Suspended |
0.7329 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7329 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7328 | Intermediate Similarity | NPD9266 | Approved |
0.7328 | Intermediate Similarity | NPD74 | Approved |
0.7324 | Intermediate Similarity | NPD1019 | Discontinued |
0.732 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7319 | Intermediate Similarity | NPD17 | Approved |
0.7299 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7292 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7286 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7273 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD9494 | Approved |
0.726 | Intermediate Similarity | NPD1613 | Approved |
0.726 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.726 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7252 | Intermediate Similarity | NPD9263 | Approved |
0.7252 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7252 | Intermediate Similarity | NPD9264 | Approved |
0.7252 | Intermediate Similarity | NPD9267 | Approved |
0.7246 | Intermediate Similarity | NPD1651 | Approved |
0.7237 | Intermediate Similarity | NPD2354 | Approved |
0.7234 | Intermediate Similarity | NPD4749 | Approved |
0.7214 | Intermediate Similarity | NPD1535 | Discovery |
0.7211 | Intermediate Similarity | NPD6355 | Discontinued |
0.7208 | Intermediate Similarity | NPD4662 | Approved |
0.7208 | Intermediate Similarity | NPD4661 | Approved |
0.72 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7195 | Intermediate Similarity | NPD2403 | Approved |
0.7183 | Intermediate Similarity | NPD1283 | Approved |
0.7174 | Intermediate Similarity | NPD1894 | Discontinued |
0.7168 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7153 | Intermediate Similarity | NPD405 | Clinical (unspecified phase) |
0.7153 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7151 | Intermediate Similarity | NPD4287 | Approved |
0.7143 | Intermediate Similarity | NPD3142 | Approved |
0.7143 | Intermediate Similarity | NPD3140 | Approved |
0.7124 | Intermediate Similarity | NPD3887 | Approved |
0.7117 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7113 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7107 | Intermediate Similarity | NPD37 | Approved |
0.7107 | Intermediate Similarity | NPD6280 | Approved |
0.7107 | Intermediate Similarity | NPD6279 | Approved |
0.7103 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7101 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7091 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD2355 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7086 | Intermediate Similarity | NPD2353 | Approved |
0.7083 | Intermediate Similarity | NPD6917 | Clinical (unspecified phase) |
PubChem CID   | 637162 |
ChEMBL   | CHEMBL255287 |
ZINC   |
Molecular Weight:   | 302.12 |
ALogP:   | -1.1908 |
MLogP:   | 2.78 |
XLogP:   | 2.587 |
# Rotatable Bonds:   | 10 |
Polar Surface Area:   | 75.99 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 2 |
# Rings:   | 2 |
# Heavy Atoms:   | 22 |